eGFR Slope & Kidney Trajectory Tool
A single lab test is only a snapshot. Nephrologists evaluate kidney disease by your eGFR slope: the rate of filtration change over time. Enter 2 or more historical readings to calculate your annual rate of decline and visualize your long-term trajectory.
Clinical standard: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD.
Enter Your Historical eGFR Readings
Enter at least 2 readings from past blood tests with their dates (earliest to latest).
| # | Test Date | eGFR Value (mL/min/1.73m²) | Action |
|---|
The KDIGO eGFR Slope Classification Explained
Your rate of annual eGFR loss provides crucial insight into whether your kidney function is maintaining healthy equilibrium or experiencing accelerated nephron attrition:
Stable / Age-Appropriate Decline
Decline of < 1.0 mL/min/yearConsistent with normal human aging. The nephron loss is gentle and typically does not lead to kidney failure within a patient's natural lifetime.
Moderate CKD Progression
Decline of 1.0 to 4.9 mL/min/yearIndicates active underlying stress on renal microvasculature (often driven by hypertension, mild proteinuria, or diabetes). Protective therapies can flatten this line.
Rapid Progression (High Alert)
Decline of ≥ 5.0 mL/min/yearSignals accelerated renal injury requiring urgent nephrology intervention. Patients in this tier benefit most from aggressive blood pressure control and combination protective drugs.
Prepare for Your Next Nephrology Consultation
Take your calculated eGFR slope directly to your doctor. Use our free Doctor Visit Prep Checklist to generate a tailored 1-page printable question list for your appointment.
Frequently Asked Questions
What is considered a normal rate of eGFR decline as we age?
Starting around age 40, healthy individuals naturally lose approximately 0.75 to 1.0 mL/min/1.73m² of eGFR per year as part of the normal physiological aging process. A decline within this range is generally considered expected and non-progressive.
How does KDIGO define "rapid progression" in chronic kidney disease?
Under Kidney Disease: Improving Global Outcomes (KDIGO) guidelines, rapid progression is defined as a sustained decline in eGFR of 5 mL/min/1.73m² or more per year, or a cumulative loss of greater than 10 mL/min/1.73m² over five years. Rapid progressors require urgent nephrological intervention.
Why does my eGFR fluctuate up and down between routine tests?
eGFR is calculated from serum creatinine, which is sensitive to temporary factors including hydration status, recent intense exercise, high cooked red meat intake, or temporary medications (like NSAIDs or starting an ACE inhibitor). A temporary 3 to 5 point bounce is common; what matters clinically is the multi-year trajectory line.
Can an eGFR slope be flattened or reversed?
Yes. While established scar tissue (fibrosis) in the kidney cannot be erased, the rate of future decline can be dramatically slowed or stabilized. Modern kidney-protective therapies (such as SGLT2 inhibitors, ACE inhibitors, ARBs, nonsteroidal MRAs, strict blood pressure control, and smoking cessation) frequently flatten the slope and preserve remaining function for decades.